Nature Medicine, Published online: 04 January 2021; doi:10.1038/s41591-020-1131-x
Liver metastases reduce clinical and preclinical immune-checkpoint inhibitor efficacy through hepatic siphoning of circulating activated CD8+ T cells, but therapeutic benefit can be improved by combining immunotherapy with liver-directed radiotherapy.
Source: Nature Medicine